Login

Serge Van Herck, CEO of EVS, presents at IBC2023. 00:10:00

Share On Facebook Share On Twitter

Serge Van Herck is the Chief Executive Officer at EVS Broadcast Equipment.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Unlocking growth and quality in the Nordic real estate market through strategic urban retail specialization | Marcel Kokkeel, CEO, Citycon Oyj.
00:10:00
Fund is a venture captal fund managed by Belltower Fund Group|Immad Akhund,Investor,Immad Akhund Fund
00:10:00
Blue Jay Mining: Advancing High-Grade Ilmenite Assets in Greenland
00:10:00
investment firm focused on unlocking unsung potential|Michael Basch,Founder, General Partner CEO,Atento Capital
00:10:00
Aurora Davidson, CEO of Amerigo Resources, Discusses Financial Success, Dividend Strategy, and Operational Efficiency in Chile
00:10:00
Advice and Insights from a Veteran CEO at a 95-Year-Old Company
00:10:00
Terry Turner, CEO of Pinnacle Financial Partners, shares expectations for company expenses and growth on 'Money Movers'.
00:00:00
Clinical Trials for Special Populations - Dr. Robert Jacobson, a Professor of Pediatric and Adolescent Medicine
00:10:00
Eric led investments in enterprise software companies such as Confluent and Amplitude, both of which IPO'ed in 2021. 
00:10:00
Kennametal: Innovating Across Industries Worldwide | Christopher Rossi - CEO of Kennametal
00:10:00
CyanConnode's Robust Finances, Strategic Partnerships, and Promising Pipeline Propel Growth | John Cronin, Executive Chairman of cyanconnode holdings plc
00:00:00
Destiny Pharma's nasal spray project already delivering "more than hoped for" - Neil Clark , CEO, Destiny Pharma

© 2017 - Neuhu+